|
C. M. Gupta (born, Sept 1, 1944) is a scientist from India. ==Education and research== Gupta graduated in medicinal chemistry from the Central Drug Research Institute (Lucknow, India with the degrees MSc and PhD. He served as the director of the Institute of Microbial Technology, Chandigarh for five years, and director of the Central Drug Research Institute (CDRI), Lucknow for over ten years. He is working as distinguished biotechnologist at the Central Drug Research Institute. His areas of specialization are membrane biochemistry/biophysics and medicinal chemistry . He has extensively contributed in the areas of drug targeting in parasitic diseases and membrane phospholipids transbilayer dynamics, and is working on elucidation of actin cytoskeletal network in Leishmania. These studies have resulted in publication of about 131 original research papers, 10 review articles, 5 book chapters and 6 patents. He has received several honors and awards and has served as a member of a number of important national and international committees. He is the DBT distinguished fellow at CDRI. He along with CDRI scientists have been accused of attempted fraud bid for a clinical isolates that was published in an International journal.〔http://www.hindustantimes.com/news-feed/nm9/cdri-scientists-accused-of-fraud-bid/article1-90343.aspx〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「C. M. Gupta」の詳細全文を読む スポンサード リンク
|